SecBot SecBot

LFWD

Lifeward Ltd.
Nasdaq· Orthopedic, Prosthetic & Surgical Appliances & Supplies· Inc. L3· CIK 0001607962 Healthcare & Medical Devices
$3.62 −0.44 (−10.84%)
Nov 16 4:00 PM ET · prev $4.06
Market cap
$15.9M
Nano cap
Consensus
Buy
88% Buy or better · 8 analysts
Median target
🔒 Subscribers only
1 year
−49.3%
from $7.14 · Nov 17
30 days
−39.0%
from $5.93
52-week range
$3.62–9.12
at the low
Avg volume 20D
23.6K
Nov 2 spike 94.5K
Short interest
87.3K
≈3.1% of shares · −2.6%
Days to cover
5.0
at average volume
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
21
analyzed by SecBot
SecBot read BEARISH 7 reports · 90 days
Balance 3 bearish · 0 bullish · 4 neutral oldest → newest, height = score
Avg score ·High conf. 7/7

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q3 2026: 1 added (0 new), 0 trimmed or exited.

  • AnalystsBULLISH

    7 of 8 rate it Buy or better.

  • Short sellersSTEADY

    Short interest −2.6% to 87.3K shares. 5.0 days to cover, ≈3.1% of shares.

  • TrendDOWNTREND

    42% below its 50-day average. New closing low $3.62 on Nov 16.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
OSAIC HOLDINGS, INC.DOUBLED226$1.5K
MORGAN STANLEYADD274$2.1K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

8 analysts
Buy 88% rate it Buy or better
Strong Buy2Buy5Hold1Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Nov 16, 2026🔒 Fresh data, subscribers only
MAINTAIN
MAINTAIN
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Aug 20, 2026
Gabay Avraham
Director
Aug 20, 2026
AWARD13,643 sh
Aug 14, 2026
Zamir Haggai
Director
Aug 14, 2026
AWARD6,711 sh
Aug 14, 2026
Greenwald Yonason
Director
Aug 14, 2026
AWARD6,711 sh
May 1, 2026
Rose Keith Dale
Chief Medical Officer
May 1, 2026
AWARD15,000 sh
Mar 25, 2026
Kidron Miriam
Director
Mar 25, 2026
AWARD7,657 sh
Mar 25, 2026
KIDRON NADAV
Director
Mar 25, 2026
AWARD7,657 sh
Mar 25, 2026
Sigsbee William Mark
Director
Mar 25, 2026
AWARD11,485 sh
Mar 25, 2026
Rozenbaum Moshe H
Director
Mar 25, 2026
AWARD11,485 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 30, 2026
87,325
shares short
-2.6%
vs prior settlement
5.0
days to cover
≈3.1%
of shares outstanding
Trading halts
Oct 1, 2026Volatility PauseResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 13, 2026 SEC
Lifeward reported Q3 2026 revenue of $5.4M, down 12% YoY from $6.2M, missing the $7.2M consensus. GAAP net loss per…
PRESS-RELEASE · Impact 6/10
Nov 13, 2026 Earnings
Lifeward Reports Third Quarter 2026 Financial Results and Provides Business Update
AlterG revenue increased 18% year-over-year to $3.6 million, driven by higher U.S. unit shipments, s
Nov 12, 2026 SEC
Ariel Kallner filed a Form 3 initial statement of beneficial ownership with Lifeward Ltd., reporting no securities…
3 · Impact 1/10
Nov 3, 2026 SEC
Ronen Tsimerman filed a Form 3 initial statement of beneficial ownership upon becoming Chief Financial Officer of…
3 · Impact 2/10
Sep 30, 2026 Inst.
OSAIC HOLDINGS, INC. · DOUBLED
226 shares ($1.5K)
Aug 20, 2026 Insider
Gabay Avraham was granted 13,643 shares
Director
Aug 14, 2026 Insider
Zamir Haggai was granted 6,711 shares
Director
Aug 14, 2026 Insider
Greenwald Yonason was granted 6,711 shares
Director

Washington

Corporate Lobbying

2 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

SecBot reports

21 filings · 4 press releases · 0 bullish · 9 bearish · 1 mixed · 11 neutral
All LFWD filing & press-release reports (25)